Andrew Cooper

Andrew Cooper is a pharmaceutical professional with extensive experience across various sectors, including Quality & Compliance, Internal Audit, Business Management & Strategy, R&D, Clinical Development, and Global Medical Affairs. They served as the Head of Audit (R&D, Medical & GPPM) in Group Internal Audit, reporting to the Chief Audit Executive and accountable to the Audit Committee and AZ Board. Previously, Andrew held multiple roles at AstraZeneca, including Associate Director of Strategy & Performance and Section Director of Compliance Advice & Assurance. They also gained experience as a Senior Clinical Scientist at Bristol-Myers Squibb and as a Senior Specialist in Global Clinical Quality Assurance at Johnson & Johnson.